<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Excess activation of ionotropic <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> receptors and iron is believed to contribute to free radical production and neuronal <z:hpo ids='HP_0011420'>death</z:hpo> following hypoxic <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>We examined the possibility that both <z:chebi fb="0" ids="31882">NMDA</z:chebi> receptor activation and <z:e sem="disease" ids="C0282193" disease_type="Disease or Syndrome" abbrv="">iron overload</z:e> determine spatial and temporal patterns of free radical production after transient middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (tMCAO) in male Sprague-Dawley rats </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0001427'>Mitochondrial</z:hpo> free radical (MFR) levels were maximally increased in neurons in the core at 1 h and 24 h after tMCAO </plain></SENT>
<SENT sid="3" pm="."><plain>Early MFR production was blocked by administration of MK-801, an <z:chebi fb="0" ids="31882">NMDA</z:chebi> receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi>, but not <z:chebi fb="0" ids="4356">deferoxamine</z:chebi>, an iron <z:chebi fb="0" ids="38161">chelator</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>Neither MK-801 nor <z:chebi fb="0" ids="4356">deferoxamine</z:chebi> attenuated late MFR production in the core </plain></SENT>
<SENT sid="5" pm="."><plain>Increased MFRs were observed in penumbral neurons within 6 h and gradually increased over 24 h after tMCAO </plain></SENT>
<SENT sid="6" pm="."><plain>Slowly-evolving MFRs in the core and penumbra were accompanied by <z:e sem="disease" ids="C0282193" disease_type="Disease or Syndrome" abbrv="">iron overload</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain><z:chebi fb="0" ids="4356">Deferoxamine</z:chebi> blocked <z:e sem="disease" ids="C0282193" disease_type="Disease or Syndrome" abbrv="">iron overload</z:e> but reduced MFR production only in the penumbra </plain></SENT>
<SENT sid="8" pm="."><plain>Combined MK-801/<z:chebi fb="0" ids="4356">deferoxamine</z:chebi> reduced late MFR production in both core and penumbra in an additive manner </plain></SENT>
<SENT sid="9" pm="."><plain>Combination therapy significantly ameliorated infarction compared with monotherapy </plain></SENT>
<SENT sid="10" pm="."><plain>These findings suggest that the <z:chebi fb="0" ids="31882">NMDA</z:chebi> receptor activation and <z:e sem="disease" ids="C0282193" disease_type="Disease or Syndrome" abbrv="">iron overload</z:e> mediate late MFR production and infarction after tMCAO </plain></SENT>
</text></document>